Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors

NCT00003125 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Esophageal Cancer
Gastric Cancer
Lung Cancer
Pancreatic Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: ALVAC-CEA vaccine
BIOLOGICAL: aldesleukin
BIOLOGICAL: sargramostim
BIOLOGICAL: vaccinia-CEA vaccine

Sponsor

Georgetown University

Collaborators

[object Object]